Back to GetFilings.com



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended March 31, 2005

Commission File Number 1-9014

Chyron Corporation

(Exact name of registrant as specified in its charter)

 

New York

 

11-2117385

(State or other jurisdiction of incorporation or organization)

 

(IRS Employer Identification No.)

5 Hub Drive, Melville, New York

 

11747

(Address of principal executive offices)

 

(Zip Code)

(631) 845-2000

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

Yes

X

No

   

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act).

Yes

 

No

X

 

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practical date.

Common Stock $.01 Par Value - 41,343,349 as of May 1, 2005

This document consists of 19 pages

 


 

CHYRON CORPORATION

INDEX

 

 

PART I

FINANCIAL INFORMATION

Page

     

Item 1.

Financial Statements

 
 

  Consolidated Balance Sheets as of March 31, 2005 (unaudited)

 
 

    and December 31, 2004

3

 

  Consolidated Statements of Operations and Comprehensive

 
 

    Income/ Loss (unaudited) for the Three Months ended

 
 

    March 31, 2005 and 2004

4

 

  Consolidated Statements of Cash Flows (unaudited) for the Three

 
 

    Months ended March 31, 2005 and 2004

5

 

  Notes to Consolidated Financial Statements (unaudited)

6

     

Item 2.

Management's Discussion and Analysis of Financial Condition

 
 

  and Results of Operations

11

     

Item 3.

Quantitative and Qualitative Disclosure About Market Risk

17

     

Item 4.

Controls and Procedures

18

     

PART II

OTHER INFORMATION

 
     

Item 1.

Legal Proceedings

18

     

Item 6.

Exhibits

18

     

 

2


 

CHYRON CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands, except share amounts)

Unaudited

 
 

March 31,

December 31,

ASSETS

2005

2004

Current assets:

   Cash and cash equivalents

$1,184

$2,855

   Accounts receivable, net

4,470

3,388

   Inventories, net

2,398

2,570

   Prepaid expenses and other current assets

   754

   718

     Total current assets

8,806

9,531

     

Property and equipment, net

674

745

Other assets

     30

       29

TOTAL ASSETS

$9,510

$10,305

     

LIABILITIES AND SHAREHOLDERS' DEFICIT

   
     

Current liabilities:

   

   Accounts payable and accrued expenses

$3,878

$3,215

   Convertible debentures

 

1,239

   Deferred revenue

810

934

   Pension liability

377

362

   Capital lease obligations

       5

       8

     Total current liabilities

5,070

5,758

     

Convertible debentures

4,017

3,979

Pension liability

1,647

1,664

Other liabilities

     368

     225

     Total liabilities

11,102

11,626

     

Commitments and contingencies

   
     

Shareholders' deficit:

   

  Preferred stock, par value without designation

   

    Authorized - 1,000,000 shares, issued - none

   

  Common stock, par value $.01

   

    Authorized - 150,000,000 shares

   

    Issued and outstanding - 41,343,349 at March 31, 2005 and

   

      41,326,016 at December 31, 2004

413

413

  Additional paid-in capital

71,973

71,968

  Accumulated deficit

(73,977)

(73,701)

  Accumulated other comprehensive loss

       (1)

       (1)

     Total shareholders' deficit

(1,592)

(1,321)

TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT

$  9,510

$10,305

 

See Notes to Consolidated Financial Statements

3


 

CHYRON CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE INCOME/LOSS
THREE MONTHS ENDED MARCH 31, 2005 AND 2004
(In thousands, except per share amounts)

(Unaudited)

 

 

2005

2004

     

Net sales

$5,975

$5,760

Cost of products sold

2,476

2,242

Gross profit

3,499

3,518

     

Operating expenses:

   

   Selling, general and administrative

3,001

2,410

   Research and development

  726

   905

     

Total operating expenses

3,727

3,315

     

Operating (loss) income

(228)

203

     

Interest expense

(66)

(153)

     

Interest income

34

14

     

Other (expense) income, net

  (16)

  262

     

Net (loss) income

(276)

  326

     

Net (loss) income per share - basic and diluted

$(0.01)

$  0.01

     

Weighted average shares outstanding:

   

  Basic

41,329

40,716

  Diluted

41,329

41,236

     

Comprehensive (loss) income:

   

   Net (loss) income

$(276)

$   326

Other comprehensive loss:

   

   Unrealized loss on securities available for sale

        

(223)

     

   Total comprehensive (loss) income

(276)

  103

 

 

See Notes to Consolidated Financial Statements

4


 

CHYRON CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
THREE MONTHS ENDED MARCH 31, 2005 AND 2004
(In thousands)
(Unaudited)

 

2005

2004

CASH FLOWS FROM OPERATING ACTIVITIES

   

Net (loss) income

$(276)

$326

Adjustments to reconcile net (loss) income used in

   

  operating activities:

   

   Depreciation and amortization

83

73

   Non-cash settlement of interest liability

59

125

   Amortization of debt issue costs

16

24

   Gain on sale of securities

 

(224)

Changes in operating assets and liabilities:

   

   Accounts receivable

(1,082)

(1,068)

   Inventories

172

(432)

   Prepaid expenses and other assets

(53)

125

   Accounts payable and accrued expenses

663

333

   Other liabilities

     17

     58

Net cash used in operating activities

(401)

(660)

     

CASH FLOWS FROM INVESTING ACTIVITIES

   

Acquisitions of property and equipment

(12)

(174)

Portion of proceeds from sale of Pro-Bel Division

 

415

Proceeds from sale of securities

        

  289

Net cash (used in) provided by investing activities

 (12)

  530

     

CASH FLOWS FROM FINANCING ACTIVITIES

   

Payments of convertible debentures

(1,260)

(3,792)

Proceeds from exercise of stock options

5

 

Payments of capital lease obligations

       (3)

       (3)

Net cash used in financing activities

(1,258)

(3,795)

     

Change in cash and cash equivalents

(1,671)

(3,925)

Cash and cash equivalents at beginning of period

2,855

 6,968

Cash and cash equivalents at end of period

$1,184

$ 3,043

 

See Notes to Consolidated Financial Statements

5


 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

1. BASIS OF PRESENTATION

General

In the opinion of management of Chyron Corporation (the "Company"), the accompanying unaudited consolidated interim financial statements reflect all adjustments (consisting of only normal recurring adjustments) necessary to present fairly the financial position of the Company as of March 31, 2005 and the consolidated results of its operations and its cash flows for the periods ended March 31, 2005 and 2004. The results of operations for such interim periods are not necessarily indicative of the results that may be expected for the year ending December 31, 2005. In addition, management is required to make estimates and assumptions that affect the amounts reported and related disclosures. Estimates, by their nature, are based on judgment and available information. Also, during interim periods, certain costs and expenses are allocated among periods based on an estimate of time expired, benefit received, or other activity associated with the periods. Accordingly, actual results cou ld differ from those estimates. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been omitted pursuant to the rules and regulations of the Securities and Exchange Commission. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2004. The December 31, 2004 figures included herein were derived from such audited consolidated financial statements.

Nature of Business

Chyron Corporation and its wholly-owned subsidiaries ("Chyron" or the "Company") is a supplier of character generators ("CG") and graphics hardware and software related products to the television industry. The Company develops, manufactures, markets and supports hardware and software products that enhance the presentation of live and pre-recorded video, audio and other data. Chyron's products are used in broadcast production facilities worldwide for applications including news, sports, weather and election coverage. The Company's graphics products create, manipulate, store, playback and manage content including 2D/3D text, logos, graphics, animations and video stills/clips. In January 2005, Chyron introduced the ChyTV digital signage product line providing low-cost, easy to use graphics for digital signage applications.

Our future growth and success will depend to a significant degree on the continued growth of various markets that use our products. We operate in a rapidly changing environment and must remain responsive to changes as they occur. In the event that revenues are significantly below 2005 forecasted revenues we believe we have the ability to reduce or delay discretionary expenditures, including capital purchases, and reduce headcount, according to our contingency plan so that we will have sufficient cash resources. However, there can be no assurance that we

6


 

will be able to adjust our costs in sufficient time to respond to revenue shortfalls, should that occur.

The long term success of the Company will be dependent on profitable operating results and the ability to raise additional capital should such additional capital be required. In the event the Company is unable to achieve expected goals of profitability or raise sufficient additional capital, if needed, we may have to scale back or eliminate certain parts of our operations.

In preparing contingency plans for a lower level of 2005 sales than we are currently forecasting, we have re-examined our cost structure and prepared a contingent restructuring plan that recommends, in the event it is necessary, to reduce and/or defer spending in staffing, travel, trade shows, professional fees (including for implementation of Sarbanes-Oxley Section 404), equipment, and bonuses, among other items. However, there can be no assurance we would be able to execute the plans in adequate time to provide a significant immediate or short-term benefit and if implemented, could have an adverse effect on our ability to conduct business.

We believe that cash on hand, net cash to be generated in the business, and availability under our line of credit, will be sufficient to meet our cash needs for the next twelve months if we are able to achieve our planned results of operations. However, there can be no assurance we will be able to achieve our plan. Furthermore, there can be no assurance that our bank will permit us to borrow under our line of credit if we fail to meet financial covenants and other requirements of the agreement. However, based on our current estimates, we believe we will be in compliance with such covenants and that such borrowings will be available to the Company.

Net Income (Loss) Per Share

For the three month period ending March 31, 2005 common stock equivalents of 9.9 million shares were not included in the computation of diluted net loss per common share because their effect would have been antidilutive.

2. MARKETABLE SECURITY

The Company had an investment in equity securities of vizrt Ltd. that was sold in the first quarter of 2004 and resulted in a gain of $0.2 million which is included in other income.

3. INVENTORIES

Inventories, net is comprised of the following (in thousands):

 

March 31,

December 31,

 

2005

2004

Finished goods

$ 787

$ 777

Work-in-progress

513

466

Raw materials

1,098

1,327

 

$2,398

$2,570

 

7


 

4. EQUITY BASED COMPENSATION

We account for our stock compensation plans in accordance with the provisions of Accounting Principles Board Opinion No. 25, "Accounting for Stock Issued to Employees" ("APB 25"), and its related interpretations, which requires that compensation cost be recognized on the date of grant for stock options issued based on the difference, if any, between the fair market value of our stock and the exercise price. Under this intrinsic value method prescribed under APB 25 there was no compensation expense recognized for the three month periods ended March 31, 2005 and 2004. We have adopted the disclosure requirements of SFAS 123, "Accounting for Stock-Based Compensation," as amended by SFAS No. 148, "Accounting for Stock-Based Compensation - Transition and Disclosure" which allows entities to continue to apply the provisions of APB 25 for transactions with employees and provides pro-forma earnings disclosures for employee stock grants as if the fair value b ased method of accounting in SFAS No. 123 had been applied to these stock grants. The following table illustrates the effect on net (loss) income and net (loss) income per common share if the fair value method had been applied (in thousands except per share amounts):

 

 

Three Months Ended

 

   March 31,

 

2005

2004

Net (loss) income

$   (276)

$  326

  Total stock-based compensation (expense) income

   

    determined under fair value based method,

   

    net of related tax effects

   (753)

  14

Pro forma net (loss) income

$(1,029)

$  340

Earnings per share:

   

  Basic - as reported

$(0.01)

$0.01

  Basic - pro forma

(0.02)

0.01

  Diluted - as reported

(0.01)

0.01

  Diluted - pro forma

(0.02)

0.01

Pursuant to authorization received from the Board of Directors, on February 3, 2005 the Company accelerated the vesting of certain outstanding unvested stock options with an exercise price of greater than $0.47 per share. These options were originally scheduled to vest in equal increments at the end of each of the first, second and third years following their grant date. Options representing the right to purchase a total of 100,000 shares that were previously granted to non-employee Directors of the Board of Directors, and that would otherwise qualify for this acceleration, were excluded from the acceleration of vesting.

The Company accelerated these options in advance of the effective date of, and in anticipation of the detrimental earnings effect of, Statement of Financial Accounting Standards No. 123 "Share-Based Payment" ("SFAS 123R"), which was issued in December 2004. SFAS 123R will require that beginning January 1, 2006 (originally July 1, 2005), the Company record as compensation expense in its statement of operations the value of employee stock options. Until the Company commences accounting for stock options under SFAS 123R in 2006, it will continue its practice of accounting for stock options in accordance with the provisions of APB

8


 

25. The Company's decision to accelerate the vesting of the options was due to its desire to avoid recording compensation expense for these options in its statement of operations in future years when these options were originally scheduled to vest. Assuming a January 1, 2006 effective date, the financial effect of this acceleration is to reduce compensation expense in the Company's pre-tax earnings by $0.29 million in 2006 and $0.15 million in 2007. This sums to $0.44 million of the $0.75 million shown in the table above. As a result of the acceleration of vesting, options to purchase 1,503,939 shares of the Company's common stock became immediately exercisable. The following table summarizes the accelerated stock options:

Exercise

Number of Option Shares Accelerated from

Price

Original Vesting in

2005

2006

2007

Total

$0.67

0

400,611

400,611

801,222

0.62

73,333

73,333

73,334

220,000

0.51

0

1,500

1,500

3,000

0.48

159,905

159,906

159,906

   479,717

233,238

635,350

635,351

1,503,939

5. SUBORDINATED CONVERTIBLE DEBENTURES

 

March 31,

December 31,

 

2005

2004

Series C Convertible Debentures

$1,260

$2,478

Series D Convertible Debentures

2,757

2,740

 

$4,017

$5,218

In late 2003 and early 2004, we closed on two exchange offers whereby previously outstanding Series A and B Debentures were exchanged for new Series C Subordinated Convertible Debentures ("Series C Debentures") and new Series D Subordinated Convertible Debentures ("Series D Debentures"). The Series C Debentures bear interest annually at 7%, payable in kind, and can be converted to common stock at a per share conversion price of $1.50. In March 2005, all holders of the Company's Series C Debentures agreed to an amendment that resulted in payment by the Company on March 31, 2005, of a total of $1.26 million, representing 50% of their principal and accrued interest balance on March 31, 2005. The amendment also provides an extension of the due date for the remainder of the principal of $1.26 million and accrued interest to April 30, 2006. All other original terms of the Series C Debentures remain the same. The Series D Debentures, which total $2.8 million, bear interest an nually at 8%, payable in kind, will mature December 31, 2006 and carry a per share conversion price of $0.65.

6. CREDIT FACILITY

The Company has a $2.5 million working capital line of credit with a U.S. bank which runs through April 14, 2006. The Company has the ability to borrow on a revolving credit basis based on levels of eligible accounts receivable. At March 31, 2005 and December 31, 2004 available borrowings on this basis were $2.5 million and $1.6 million, respectively. Interest will

9


 

be payable at prime +1.5%, where prime is a minimum 4%, and we will be required to maintain certain levels of tangible net worth and cash or availability of $0.5 million. At March 31, 2005 and throughout the term of our arrangement with our U.S. bank we have been in compliance with our financial covenants. Throughout 2004 and 2005, there was no outstanding indebtedness under this line of credit or with any financial institution.

7. BENEFIT PLANS

The net periodic benefit cost for the three months ended March 31 was as follows (in thousands):

 

2005

2004

     

Service cost

$  74

$  71

Interest cost

42

37

Expected return on plan assets

(31)

(27)

Amortization of prior service cost

(9)

(9)

Amortization of prior gain

 (2)

(14)

 

$  74

$  58

During the quarter ended March 31, 2005 we made contributions of $0.08 million to the Pension Plan. We expect to contribute $0.4 million over the next twelve months.

8. GEOGRAPHIC INFORMATION

The details of the Company's geographic sales are as follows (in thousands):

 

Three Months Ended

 

March 31,

 

2005

2004

     

United States

$4,965

$4,574

Germany

403

112

Canada

174

202

Other

433

872

9. RECENT ACCOUNTING PRONOUNCEMENTS

In November 2004, the FASB issued Statement of Financial Accounting Standards No. 151, an amendment of ARB No. 43, Chapter 4, Inventory Costs (SFAS No. 151). This accounting standard, which is effective for annual periods beginning after June 15, 2005, requires that abnormal amounts of idle facility expense, freight, handling costs, and wasted materials (spoilage) should be recognized as current-period charges. The adoption of SFAS No. 151 is not expected to have a material effect on the Company's financial position or results of operations.

In December 2004, the FASB issued SFAS No. 153, "Exchanges of Nonmonetary Assets," an amendment of APB Opinion No. 29, "Accounting for Nonmonetary Transactions." SFAS No. 153 addresses the measurement of exchanges of nonmonetary assets and redefines the scope of transactions that should be measured based on the fair value of the assets exchanged. SFAS No. 153 is effective for nonmonetary asset exchanges occurring in 2006. We do not believe the adoption of SFAS No. 153 will have a material effect on the Company's financial position or results of operations.

 

10


 

In December 2004, the FASB issued FAS No. 123R, "Share-Based Payment." FAS No. 123R supercedes APB No. 25, FAS No. 123, as amended by FAS No. 148, and related interpretations. Under FAS No. 123R, compensation cost is measured at the grant date based on the estimated fair value of the award and is required to be recognized as compensation expense over the vesting period. FAS No 123R would have been effective for the Company on July 1, 2005. However, in April 2005, the Securities and Exchange Commission delayed its effective date for financials filed with the SEC, and as a result the Company plans to adopt FAS No. 123R in the first quarter of 2006.

Pursuant to authorization received from the Board of Directors, on February 3, 2005, the Company accelerated the vesting of certain outstanding unvested stock options with an exercise price of greater than $0.47 per share. The Company accelerated these options in advance of the original July 1, 2005 effective date of, and in anticipation of the detrimental earnings effect of SFAS 123R. The Company's decision to accelerate the vesting of the options was due to its desire to avoid recording compensation expense for these options in its statement of operations in future years when these options were originally scheduled to vest. Note 4 to the Company's consolidated financial statements presents the pro forma net income (loss) the Company would have recognized had compensation costs for the Company's incentive compensation plans been determined consistent with FAS No. 123. Also included in Note 4 is the financial effect of the Q1 2005 acceleration of such options.

Therefore, based on grants that are currently outstanding and the elimination of the expense related to the accelerated vesting, the Company does not believe that the adoption of this standard will have a material impact on its financial position or results of operations. However, depending on the amount of options granted in the future, and their estimated value, both of which are unknown at this time, the adoption of this standard in the first quarter of 2006 could have a material impact on the Company's results of operations and financial position.

Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL

            CONDITION AND RESULTS OF OPERATIONS

From time to time, including in this Quarterly Report on Form 10-Q, we may publish forward-looking statements relating to such matters as anticipated financial performance, business prospects, technological developments, changes in the industry, new products, research and development activities and similar matters. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for such forward-looking statements. In order to comply with the terms of the safe harbor, we note that a variety of factors could cause our actual results to differ from the anticipated results or other expectations expressed in our forward-looking statements.

11


 

The risks and uncertainties that may affect the operations, performance, development and results of our business include, without limitation, the following: product concentration in a mature market, dependence on the emerging digital market and the industry's transition to DTV and HDTV, consumer acceptance of DTV and HDTV, resistance within the broadcast or cable industry to implement DTV and HDTV technology, use and improvement of the Internet, new technologies that could render certain Chyron products to be obsolete, a highly competitive environment, competitors with significantly greater financial resources, new product introductions by competitors, seasonality, fluctuations in quarterly operating results, ability to maintain adequate levels of working capital, viability of the OTC Bulletin Board as a trading platform, and expansion into new markets. Additional factors affecting future results, and which are described in more detail in our Annual Report on Form 10-K for the year ended December 31, 2004, include:

12


 

Results of Operations

This discussion should be read in conjunction with the Consolidated Financial Statements including the Notes thereto.

 

13


 

Comparison of the Three Months Ended March 31, 2005 and 2004

Revenues for the quarter ended March 31, 2005 were $6.0 million, an increase of $0.2 million, or 3% from the $5.8 million reported for the first quarter of 2004. Revenues in the U.S. were $5.0 million in the first quarter of 2005 as compared to $4.6 million in the first quarter of 2004. International revenues were $1.0 million in the first quarter of 2005 as compared to $1.2 million in the first quarter of 2004. Domestic revenues have increased primarily from the sales of Duet HyperX systems which can be configured as HD, SD or a combination of both, offering a highly flexible and scalable migration path to high definition broadcasting. Also contributing to this growth is the continued acceptance of Duet LEX by major sports programmers.

Gross margins for the first quarter of 2005 were 59% compared to 61% in the comparable quarter in 2004. The decline in margins was due primarily to product mix and higher discounts on certain product lines.

Selling, general and administrative (SG&A) expenses increased by $0.6 million, to $3.0 million in the quarter ended March 31, 2005, compared to $2.4 million in the first quarter of 2004. The primary expense items contributing to the increase were SG&A expenses attributable to the rollout of the ChyTV digital signage product line of $0.3 million, severance costs of $0.1 million, professional services for Sarbanes-Oxley compliance and other consulting of $0.1 million, and increased employee benefit costs of $0.1 million.

Research and development (R&D) costs of $0.7 million in the first quarter of 2005 decreased by $0.2 million compared to the $0.9 million incurred in the first quarter of 2004. Reductions in 2005 spending are a result of lower project materials of $0.1 million and reduced costs of personnel and use of consultants of $0.1 million.

Interest expense in the first quarter of 2005 approximated $0.07 million as compared to $0.15 million in the first quarter of 2004. This is a direct result of the combination of lower borrowings and lower interest rates on the underlying debt instruments. In the fourth quarter of 2003 and first quarter of 2004 we closed on two exchange offers which resulted in the retirement of approximately $6 million of Series A and B debentures, with the balance exchanged for Series C and D debentures which carry a lower rate of interest. The combination of these factors reduced interest expense by $0.08 million.

The components of other income (expense), net are as follows (in thousands):

 

Three Months Ended

 

March 31,

 

2005

2004

Gain on sale of securities

 

$224

Foreign exchange transaction (loss) gain

$ (30)

40

Other

  14

  (2)

 

(16)

$262

 

14


 

In the first quarter of 2004, we sold our remaining investment in equity securities of vizrt Ltd. and realized a gain of $0.2 million.

Liquidity and Capital Resources

At March 31, 2005, we had cash on hand of $1.2 million and working capital of $3.7 million.

During the three months ended March 31, 2005, net cash of $0.4 million was used by operations and $1.26 million was used to retire a portion of our Series C Debentures. The utilization of cash from operations was driven by the net loss in the quarter, an increase in receivables from sales that were realized late in the quarter, and therefore not yet collectable, delays in collection of several customer receivables and partially offset by $0.7 million from the increase in accounts payable and accrued expenses.

In March 2005, we amended the Series C Debentures such that half of the principal and accrued interest at March 31, 2005, became due and payable on that date and the remaining half of the principal, plus accrued interest through April 30, 2006, becomes due and payable on that date. As per the amended Series C Debenture terms, on March 31, 2005, $1.26 million was paid to holders and the remaining principal of $1.26 million, plus accrued interest, will be due on April 30, 2006. The Series D Debentures, which total $2.8 million, and bear interest annually at 8%, payable in kind, will mature December 31, 2006.

The Company received $0.4 million in May 2005 which represents the final payment of the proceeds from the sale of Pro-Bel.

The Company has a $2.5 million working capital line of credit with a U.S. bank which runs through April 14, 2006. The Company has the ability to borrow on a revolving credit basis based on levels of eligible accounts receivable. At March 31, 2005 and December 31, 2004 available borrowings on this basis were $2.5 million and $1.6 million, respectively. Interest will be payable at prime +1.5%, where prime is a minimum 4%, and we will be required to maintain certain levels of tangible net worth and cash or availability of $0.5 million. At March 31, 2005 and throughout the term of our arrangement with our U.S. bank we have been in compliance with our financial covenants. Throughout 2004 and 2005, there was no outstanding indebtedness under this line of credit or with any financial institution.

We provide graphics products to the broadcast industry for use in digital television. Our future growth and success will depend to a significant degree on the continued growth of various markets that use our products. We operate in a rapidly changing environment and must remain responsive to changes as they occur. In the event that revenues are significantly below 2005 forecasted revenues we believe we have the ability to reduce or delay discretionary expenditures, including capital purchases, and reduce headcount, according to our contingency plan so that we will have sufficient cash resources. However, there can be no assurance that we will be able to adjust our costs in sufficient time to respond to revenue shortfalls, should that occur.

15


 

The long term success of the Company will be dependent on profitable operating results and the ability to raise additional capital. In the event the Company is unable to achieve expected goals of profitability or raise sufficient additional capital, we may have to scale back or eliminate certain parts of our operations.

In preparing contingency plans for a lower level of 2005 sales than we are currently forecasting, we have re-examined our cost structure and prepared a contingent restructuring plan that recommends, in the event it is necessary, to reduce and/or defer spending in staffing, travel, trade shows, professional fees (including for implementation of Sarbanes-Oxley Section 404), equipment, and bonuses, among other items. However, there can be no assurance we would be able to execute the plans in adequate time to provide a significant immediate or short-term benefit and if implemented, could have an adverse effect on our ability to conduct business.

We believe that cash on hand, net cash to be generated in the business, and availability under our line of credit, will be sufficient to meet our cash needs for the next twelve months if we are able to achieve our planned results of operations. However, there can be no assurance we will be able to achieve our plan. Furthermore, there can be no assurance that our bank will permit us to borrow under our line of credit if we fail to meet financial covenants and other requirements of the agreement. However, based on our current estimates, we believe we will be in compliance with such covenants and that such borrowings will be available to the Company.

Recent Accounting Pronouncements

In November 2004, the FASB issued Statement of Financial Accounting Standards No. 151, an amendment of ARB No. 43, Chapter 4, Inventory Costs (SFAS No. 151). This accounting standard, which is effective for annual periods beginning after June 15, 2005, requires that abnormal amounts of idle facility expense, freight, handling costs, and wasted materials (spoilage) should be recognized as current-period charges. The adoption of SFAS No. 151 is not expected to have a material effect on the Company's financial position or results of operations.

In December 2004, the FASB issued SFAS No. 153, "Exchanges of Nonmonetary Assets," an amendment of APB Opinion No. 29, "Accounting for Nonmonetary Transactions." SFAS No. 153 addresses the measurement of exchanges of nonmonetary assets and redefines the scope of transactions that should be measured based on the fair value of the assets exchanged. SFAS No. 153 is effective for nonmonetary asset exchanges occurring in 2006. We do not believe the adoption of SFAS No. 153 will have a material effect on the Company's financial position or results of operations.

In December 2004, the FASB issued FAS No. 123R, "Share-Based Payment." FAS No. 123R supercedes APB No. 25, FAS No. 123, as amended by FAS No. 148, and related interpretations. Under FAS No. 123R, compensation cost is measured at the grant date based on the estimated fair value of the award and is required to be recognized as compensation expense over the vesting period. FAS No. 123R would have been effective for the Company on July 1, 2005. However, in April 2005, the Securities and Exchange Commission delayed its effective

16


 

date for financials filed with the SEC and as a result the Company plans to adopt FAS No. 123R in the first quarter of 2006.

Pursuant to authorization received from the Board of Directors, on February 3, 2005, the Company accelerated the vesting of certain outstanding unvested stock options with an exercise price of greater than $0.47 per share. The Company accelerated these options in advance of the original July 1, 2005 effective date, and in anticipation of the detrimental earnings effect of SFAS 123R. The Company's decision to accelerate the vesting of the options was due to its desire to avoid recording compensation expense for these options in its statement of operations in future years when these options were originally scheduled to vest. Note 4 to the Company's consolidated financial statements presents the pro forma net income (loss) the Company would have recognized had compensation costs for the Company's incentive compensation plans been determined consistent with FAS No. 123. Also included in Note 4 is the financial effect of the Q1 2005 acceleration of such options.

Therefore, based on grants that are currently outstanding and the elimination of the expense related to the accelerated vesting, the Company does not believe that the adoption of this standard will have a material impact on its financial position or results of operations. However, depending on the amount of options granted in the future, and their estimated value, both of which are unknown at this time, the adoption of this standard in the first quarter of 2006 could have a material impact on the Company's results of operations and financial position.

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT

            MARKET RISK

We are exposed to foreign currency and exchange risk in the normal course of business related to investments in our foreign subsidiaries and sales to foreign customers. For the three months ended March 31, 2005 and 2004, sales to foreign customers were 17% and 21% of total sales, respectively. All sales generated outside of the U.S. are denominated in British Pounds Sterling, Euros and U.S. Dollars.

The net impact on earnings of foreign exchange transactions was a loss of $0.03 million in the three month period ended March 31, 2005 and a gain of $0.04 in the three month period ended March 31, 2004. We record translation gain or loss as a separate component of other comprehensive income or loss in shareholders' equity (deficit).

Additionally, we are potentially exposed to interest rate risk with respect to any bank debt which would carry a variable interest rate. Rates that affect the variable interest on this debt include the Prime Rate. Throughout 2004 and 2005, there was no outstanding indebtedness with variable interest rates. We have evaluated the foreign currency exchange risk and interest rate risk and believe that our exposure to these risks are not material to our near-term financial position, earnings, or cash flows.

 

17


 

Item 4. CONTROLS AND PROCEDURES

As of March 31, 2005, an evaluation was performed under the supervision and with the participation of the Company's management, including the Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), of the effectiveness of the design and operation of the Company's disclosure controls and procedures. Based on that evaluation, the Company's management, including the CEO and CFO, concluded that the Company's disclosure controls and procedures were effective as of March 31, 2005. There have been no significant changes in the Company's internal control over financial reporting during the most recent quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

PART II.   OTHER INFORMATION

ITEM 1.    LEGAL PROCEEDINGS

The Company from time to time is involved in routine legal matters incidental to its business. In the opinion of management, the ultimate resolution of such matters will not have a material adverse effect on the Company's financial position, results of operations or liquidity.

ITEM 6.   EXHIBITS

(a)  Exhibits:

Exhibit No.

Description of Exhibit

   

31.1

Certification of Chief Executive Officer pursuant to Rule 13A-14(a) or 15D-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

   

31.2

Certification of Chief Financial Officer pursuant to Rule 13A-14(a) or 15D-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

   

32.1

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

   

32.2

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

18


 

SIGNATURES

In accordance with the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

   

CHYRON CORPORATION

   

(Registrant)

     
     

May 13, 2005

 

/s/ Michael Wellesley-Wesley

(Date)

 

     Michael Wellesley-Wesley

   

     President and

   

     Chief Executive Officer

     

May 13, 2005

 

/s/ Jerry Kieliszak

(Date)

 

     Jerry Kieliszak

   

     Senior Vice President and

   

     Chief Financial Officer     

 

19